BURBANK, Calif., Jan. 19, 2006 (PRIMEZONE) -- Imaging3(tm), Inc. (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today provided an overview of its upcoming new product, The Dominion(tm).
"This device is unique in the medical imaging market since the 3D images will be constructed and displayed in real-time, versus the delayed imagery currently available," said Dean Janes, Imaging 3's CEO. "Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI) systems in use today, produce high quality 3D reconstructions, but do so in minutes not in the fraction of a second which is required for real time imaging. The company's Dominion product generates these images in a fraction of a second, allowing medical personnel to simultaneously perform procedures on the patient being imaged."
Mr. Janes further notes that the size and shape of these existing devices -- CT and MRI -- prohibits direct access to the patient, thus making it difficult for physicians to perform any invasive medical procedures on the patient being imaged. "These limitations in the medical imaging market are what drove us to develop this breakthrough technology," continued Mr. Janes.
The Dominion is designed to be mobile, capable of being pushed by an average person through a standard room door, and utilizes power from a standard wall outlet. Further, the Dominion is also to be capable of multiple imaging functions and therefore can replace or supplement a number of existing devices, resulting in a considerable cost savings for hospitals and healthcare centers. These functions include real-time 3D imaging, computerized tomography, (CT), and standard fluoroscopy, with several other applications in development.
One of the key safety features of the Dominion is its low dose of x-ray radiation. By utilizing a form of fluoroscopy known as photo-fluoroscopy, the Dominion produces approximately 40% to 50% lower dose output than standard fluoroscopy devices on the market today.
The Dominion has enormous potential to contribute to the improvement of healthcare. Real-time 3D images will be instantly constructed using high resolution fluoroscopy and can be continuously updated. The Dominion will be used for any current or new medical procedures, especially when multiple frames of reference are required. This new product has extraordinary market potential in an almost unlimited number of medical applications, including trauma, cardiology, pain management, orthopedics, oncology, pediatrics, interventional radiology, urology, sports medicine, computer guided surgery, and robotic assisted surgery.
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.